The down-regulated pathways in miR-22-high and Gal-1-low HCC included the GTPase cycle, matrix remodeling, O-linked glycosylation, Golgi and ER trafficking, and the cell cycle (Fig. 4). The gene discussed is LGALS1; the disease is hepatocellular carcinoma.